0000016732false00000167322026-11-172026-11-17

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report
(Date of Earliest Event Reported):
November 17, 2026
TCC-logo_V_red (002).jpg
THE CAMPBELL'S COMPANY
New Jersey1-382221-0419870
(State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer
Identification No.)
One Campbell Place
Camden, New Jersey 08103-1799
Principal Executive Offices
Telephone Number: (856) 342-4800

Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Capital Stock, par value $.0375CPBThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
At the Annual Meeting of Shareholders of The Campbell's Company (the "Company"), which was held on November 17, 2026 (the “2026 Annual Meeting”), the Company's shareholders approved the Amended and Restated 2022 Long-Term Incentive Plan (the “Amended and Restated Plan”). The Amended and Restated Plan was previously approved, subject to shareholder approval, by the Board of Directors (the “Board”) of the Company.
The Amended and Restated Plan amends and restates in its entirety the Company's 2022 Long-Term Incentive Plan (the "2022 Plan") by (i) increasing the number of shares available for issuance by 9,000,000 shares, which increases the total number of shares authorized for issuance from 12,000,000 shares to 21,000,000 shares; (ii) adding a minimum one-year vesting period term for awards, subject to customary exceptions; and (iii) making various administrative amendments approved by the Board that do not require shareholder approval according to the 2022 Plan and the rules of The Nasdaq Stock Market. A summary of the material terms and conditions of the Amended and Restated Plan and awards thereunder is included in the Company's definitive proxy statement filed with the Securities and Exchange Commission on October 7, 2026 (the “Proxy Statement”) under “Item 4: Amendment and Restatement of the Company's 2022 Long-Term Incentive Plan,” which section is incorporated herein by reference. The foregoing descriptions are qualified in their entirety by reference to the Amended and Restated Plan, a copy of which is filed as Exhibit 10.1 hereto and incorporated herein by reference.
Item 5.07 – Submission of Matters to a Vote of Security Holders
The final results of voting with respect to each item voted on at the 2026 Annual Meeting are set forth below.
Management Proposals:
1. Election of Directors
The nominees for election to the Board were elected, each until the next Annual Meeting of Shareholders or their earlier resignation or retirement. For each nominee, the votes cast for, against, abstentions, and broker non-votes were as follows:
Director
For
Against
Abstain
Broker Non-Votes
Fabiola R. Arredondo
192,056,8801,977,415384,26163,887,053
Howard M. Averill
192,013,6362,023,713381,20763,887,053
Mick J. Beekhuizen
192,395,1061,642,094381,35663,887,053
Bennett Dorrance, Jr.
191,924,1362,124,609369,81163,887,053
Maria Teresa (Tessa) Hilado
192,070,1921,994,333354,02063,887,053
Grant H. Hill
191,753,3962,280,759384,40163,887,053
Sarah Hofstetter
191,899,3512,172,062347,14363,887,053
Marc B. Lautenbach
191,182,5792,850,787385,19063,887,053
Mary Alice D. Malone, Jr.
192,001,4672,064,189352,90063,887,053
Keith R. McLoughlin
192,019,5342,028,609370,41363,887,053
Kurt T. Schmidt
191,918,6082,123,958375,99063,887,053
Archbold D. van Beuren
190,185,1293,867,931365,49663,887,053
2. Ratification of Appointment of Independent Registered Public Accounting Firm for Fiscal 2027
The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal 2027 was approved. The votes cast for and against this proposal as well as the abstentions were as follows:
For
Against
Abstain
254,644,8383,309,860350,248
3. Advisory Vote on Fiscal 2026 Executive Compensation
The resolution to approve, on an advisory basis, the compensation of the Company's executive officers named in the Proxy Statement for the 2026 Annual Meeting was approved. The votes cast for and against this proposal as well as the abstentions and broker non-votes were as follows:



For
Against
Abstain
Broker Non-Votes
189,900,6884,011,411506,45763,887,053
4. Amendment and Restatement of the Company's 2022 Long-Term Incentive Plan
The proposal to approve an amendment and restatement of the Company's 2022 Long-Term Incentive Plan was approved. The votes cast for and against this proposal as well as the abstentions and broker non-votes were as follows:
For
Against
Abstain
Broker Non-Votes
190,336,1193,578,364504,07363,887,053
Shareholder Proposal:
5. Regenerative Agriculture Program Report
A non-binding shareholder proposal regarding a report on the effectiveness of the Company’s regenerative agriculture program including pesticide reduction outcomes was not approved. The votes cast for and against this proposal as well as the abstentions and broker non-votes were as follows:
For
Against
Abstain
Broker Non-Votes
8,557,797183,754,6192,106,14063,887,053

Item 9.01 – Financial Statements and Exhibits
(d) Exhibits
10.1*
10.2*
10.3*
10.4*
10.5*
104The cover page from this Current Report on Form 8-K formatted in Inline XBRL.
*This exhibit is a management contract or compensatory plan or arrangement.



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

THE CAMPBELL'S COMPANY
       Date: November 18, 2026By:/s/ Charles A. Brawley, III
Charles A. Brawley, III
Executive Vice President, General Counsel and Corporate Secretary